Also known as: BofA Securities
Medtronic's diabetes unit MiniMed is seeking up to $7.86 billion valuation in its U.S. IPO while cutting 81 jobs at its Northridge facility ahead of the planned separation into a standalone publicly traded company.
Worldwide Clinical Trials has completed its acquisition of Catalyst Clinical Research, expanding its oncology capabilities and functional service provider model. The combined organization employs approximately 4,400 professionals across more than 70 countries.
Global pharmaceutical companies are accelerating licensing deals for China-developed experimental medicines, with deal values reaching unprecedented levels in 2026 as firms cut costs ahead of patent expirations.
